Injecto Polymers: No Deviation in IPO Fund Utilization for Q2 FY27

Injecto Polymers Limited has submitted its Statement of Deviation/Variation in the utilization of funds raised through its Initial Public Offer (IPO) for the quarter ended September 30, 2026. The company reported that there was no deviation or variation in the use of funds. The total amount raised was ₹56.12 crores. Funds were allocated to repayment of borrowings (₹10 crores), capital expenditure for Phase IV of its manufacturing facility (₹30.50 crores), general corporate purposes (₹7.28 crores), and issue expenses (₹8.34 crores). The total utilized amount up to September 30, 2026, was ₹19.32 crores. The Audit Committee and Board of Directors have reviewed and approved the statement.